Top Journals Selectivity Index: Is it acceptable for drugs beyond the field of analgesia?

Scientometrics

Volumn 88, Issue 2, 2011, Pages 589-597

  Kissin, Igor ^a   Bradley Jr , Edwin L ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Bibliometrics; Biomedical journals; Drugs; Impact Factor; Topic specific publications

Indexed keywords

EID: 79959628547     PISSN: 01389130     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11192-011-0403-0     Document Type: Article

References (7)

1. Bordons, M., Bravo, C., & Barrington, S. (2004). Time-tracking of the research profile of a drug using bibliometric tools. Journal of the American Society for Information Science and Technology, 55, 445-461.
2. Hill, R. G. (2006). Analgesic drugs in development. In S. B. McMahon & M. Koltzenburg (Eds.), Wall and Melzack's textbook of pain (5th ed., pp. 541-542). Philadelphia: Elsevier, Churchill Livingstone.
3. Kissin, I. (2010). Development of new analgesics over the past 50 years: Lack of real breakthrough drugs. Anesthesia and Analgesia, 110, 780-789.
4. Kissin, I. (2011). Can a bibliometric indicator predict the success of an analgesic? Scientometrics, 86, 785-795.
5. Koenig, M. E. D. (1982). Determinants of expert judgment of research performance. Scientometrics, 4, 361-378.
6. Mahley, R. W., & Bersot, T. P. (2006). Drug therapy for hypercholesterolemia and dyslipidemia. In L. L. Brunton, et al. (Eds.), Goodman and Gilman's pharmacological basis of therapeutics (11th ed., pp. 957-958). New York: McGraw-Hill.
7. Stafford, S., Wagner, T. H., & Lavori, P. W. (2009). New, but not improved? Incorporating comparative-effectiveness information into FDA labeling. New England Journal of Medicine, 361, 1230-1233.